Solid Biosciences (SLDB) Stock: Falling Hard On Safety Signals

Solid Biosciences SLDB Stock News

Solid Biosciences Inc (NASDAQ: SLDB) is having an overwhelmingly rough start to the trading session this morning. While the company reported its Q1 financials after the close yesterday, this has little to do with the declines. Ultimately, the fall in value has to do with the fact that the company’s Phase 1/2 clinical trial has … Read more

Cellectar Biosciences (CLRB) Stock: Gaining On Fast Track Designation

Cellectar Biosciences CLRB Stock News

Cellectar Biosciences Inc (NASDAQ: CLRB) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced that it has been granted Fast Track Designation by the FDA, exciting investors and sending the stock for the top. Today, we’ll talk about: The Fast Track Designation; what we’re seeing … Read more

Catalyst Pharmaceuticals (CPRX) Stock: Gaining Big On Financial Results

Catalyst Pharmaceuticals CPRX Stock News

Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) is having an incredibly strong start to the trading session this mroning, and for good reason. The company reported its financial results, beating expectations on all accounts. Today, we’ll talk about: The financial results; what we’re seeing from CPRX stock as a result; and what we’ll be watching for ahead. … Read more

Seelos Therapeutics (SEEL) Stock: Gaining On Analyst Initiation

Seelos SEEL Stock News

Seelos Therapeutics Inc (NASDAQ: SEEL) is having an overwhelmingly positive start to the trading session this morning, and for good reason. The company was initiated by one of the most trusted analyst firms on Wall Street, who has a positive opinion. Today, we’ll talk about: The analyst initiation; what we’re seeing from SEEL stock as … Read more

ARCA Biopharma (ABIO) Stock: Climbing On Financial Results

Arca Biopharma ABIO Stock News

ARCA Biopharma Inc (NASDAQ: ABIO) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced its financial and operational results for the most recent quarter. Today, we’ll talk about: The results; what we’re seeing from ABIO stock as a result; and what we’ll be watching for … Read more

BioLineRX (BLRX) Stock: Climbing On FDA Approval

BioLineRx BLRX Stock News

BioLineRx (NASDAQ: BLRX) is having an incredibly strong start to the trading session this mroning, and for good reason. The comapny announced an FDA approval, exciting investors and sending the stock on a run for the top. Today, we’ll talk about: The approval; what we’re seeing from BLRX stock as a result; and what we’ll … Read more

Hemispherx Biopharma (HEB) Stock: Running On Ampligen News

Hemespherx BioPharma HEB Stock News

Hemispherx BioPharma, Inc (NYSEAMERICAN: HEB) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced an update surrounding the commercialization of its Ampligen product, exciting investors and sending the stock on a run for the top. Today, we’ll talk about: The update; what we’re seeing from … Read more

Aerpio Pharmaceuticals (ARPO) Stock: Gaining On Data Presentation

Aerpio Pharmaceuticals ARPO Stock News

Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) is headed up in the market this morning after the company announced that it presented new data. As you could imagine, the data was positive, exciting investors and sending the stock up. Today, we’ll talk about: The data; what we’re seeing from ARPO stock as a result; and what we’ll … Read more

InspireMD (NSPR) Stock: Here’s Why It’s Soaring

InspireMD INSPR Stock News

InspireMD Inc (NYSEAMERICAN: NSPR) is having an overwhelmingly strong start to the trading session this moring. However, if you’re looking for a press release or an SEC filing, you’re going to be looking for quite a while. There’s nothing out this morning. In fact, the company hasn’t issued any news in some time. So, what’s … Read more

ARCA Biopharma (ABIO) Stock: Soaring Yet Again

Arca Biopharma ABIO Stock News

ARCA Biopharma Inc (NASDAQ: ABIO) is having yet another incredibly strong start to the trading session after yesterday’s tremendous gains. While there are no new press releases or SEC filings this morning, the gains are here fore good reason. Today, we’ll talk about: Why ABIO stock is running for the top; what we’re seeing from … Read more